Prelux Receives Positive Decision to Conduct a Clinical Investigation
Prelux, a system developed by Pentacomp that uses artificial intelligence to support the screening diagnosis of developmental dysplasia of the hip in infants, has received a positive decision from the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, authorising the conduct of a clinical investigation. This marks another important milestone in the development of the solution and its clinical validation process.
AI Technology Supporting Medical Diagnostics
Prelux is an innovative IT system developed by Pentacomp to support the screening diagnosis of developmental dysplasia of the hip (DDH) in infants.
The solution uses artificial intelligence algorithms to analyse ultrasound (US) images, supporting the assessment of hip joints in accordance with the Graf method. Its development reflects the growing role of modern technologies in medicine and the use of AI as a tool to support healthcare professionals and diagnostic processes.
The Next Stage: A Clinical Investigation
he decision issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products authorises the conduct of a clinical investigation entitled:“Assessment of Agreement Between the Prelux System and Standard Ultrasound Assessment in the Classification of Hip Types in Infants Undergoing Screening for Developmental Dysplasia of the Hip (DDH).”
The primary objective of the investigation is to assess the agreement between the results obtained using the Prelux system and those of standard ultrasound assessment. The investigation will provide clinical data essential for further evaluation of the solution and assessment of its potential application in clinical practice.
This is an important part of the medical device development process, combining technological expertise with the requirements and standards of the healthcare sector.
Artificial Intelligence Supporting the Development of Medicine
At Pentacomp, we consistently develop solutions that harness the potential of emerging technologies to address the specific needs of various industries. The Prelux project demonstrates how expertise in IT and artificial intelligence can be applied in healthcare.
We believe that responsibly developed technology can provide valuable support to healthcare professionals by offering additional tools for their everyday work.
Receiving a positive decision authorising the clinical investigation is an important step in the further development of Prelux. The next stage of work lies ahead, and we will keep you informed about the project’s progress.